Description

Phillips Medisize is a leading global contract development and manufacturing organization (CDMO) specializing in the design, engineering, and production of pharmaceutical drug delivery systems, medical devices, and in vitro diagnostic tools. With over 60 years of industry experience, Phillips Medisize serves some of the world's foremost pharmaceutical, medtech, and diagnostic companies, delivering innovative solutions that improve patient outcomes and quality of life. The company operates more than 30 development and manufacturing sites across 11 countries on three continents, supported by a dedicated workforce of over 6,000 employees. As a Molex company, Phillips Medisize benefits from the backing of Koch Industries, one of the largest privately held corporations globally, providing financial stability and long-term investment capabilities. The company emphasizes a personalized, collaborative approach with customers, focusing on engineering excellence, quality, and continuous improvement through its Principle Based Management™ framework. Phillips Medisize's portfolio includes advanced drug delivery systems and medical connectors such as the recently launched TheraVolt™ Medical Connectors, enhancing device integration and performance. The integration of Vectura Group Ltd.’s inhalation capabilities further broadens its offerings to pharmaceutical partners. Phillips Medisize is committed to helping people live healthier, more productive lives by providing trusted, high-quality medical solutions tailored to the evolving demands of the healthcare industry. Their client base includes a significant portion of Fortune 500 pharmaceutical and medical device companies, underscoring their reputation and market leadership.